# Combined Triple Therapy in Diabetic Retinopathy (DRP)

> **NCT00806169** · PHASE3 · COMPLETED · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Macular Edema
- Diabetic Retinopathy

## Interventions

- **DRUG:** triamcinolone and bevacizumab

## Key facts

- **NCT ID:** NCT00806169
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806169, "Combined Triple Therapy in Diabetic Retinopathy (DRP)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00806169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*